Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Yet Another Molecular Partner for Presenilins Identified
25 November 2001. Researchers from Bart de Strooper's lab at the Flanders Interuniversity Institute for Biotechnology, reported in the 20 November Neuron that telencephalin (TLN), a member of the intercellular adhesion molecule (ICAM) family, binds to presenilins 1 and 2 (PS1 and PS2), components of the amyloid precursor protein (AβPP) γ-secretase complex that is implicated in the etiology of Alzheimer's disease.

TLN was identified from a yeast two-hybrid screen of a mouse hippocampus library using a C-terminal fragment of PS1 as bait. The group subsequently separated TLN from brain extracts using an immobilized PS1 C-terminal fragment. Surprisingly, the reverse experiment, using an immobilized fragment of the TLN transmembrane domain, separated both C-terminal and N-terminal fragments of PS1, indicating that both ends of the protein bind to TLN. PS1's TLN-binding sites are amino acids 1-163, which cover the first transmembrane domain, and the 39 C-terminal residues, which are predicted to lie in the cytosol. These findings suggest that, in vivo, the PS1 molecule may form a ring structure, with the C- and N-terminals coming into contact with TLN. In addition, the same PS1 sites were found to bind to AβPP, suggesting a common mode of interaction between presenilins and their molecular partners.

"Though telencephalin, which is localized in the telencephalon and is not a PS substrate, is not directly involved in Alzheimer's disease, this data may be functionally important in understanding how presenilins work," commented Christian Haass, Ludwig-Maximilians University, Munich. "The ring structure is almost certainly correct, though proving this directly in vivo will be difficult."-Tom Fagan.

Reference:Annaert WG, Esselens C, Baert V, Boeve C, Snellings G, Cupers P, Craessaerts K, De Strooper B. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 20 November 2001;(32):579-589. Abstract

 
Comments on News and Primary Papers
  Primary Papers: Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins.

Comment by:  Eddie Koo, ARF Advisor
Permalink

Another function for ps, also related to protein degradation but not like app or notch clevage.

View all comments by Eddie Koo
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad